Surrozen Operating, Inc.
6Patents
6Active
6Granted
45Portfolio score
Filing activity: Jan 26, 2018 → Jul 28, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11746150B2 | Anti-LRP5/6 antibodies and methods of use | Chemistry; Metallurgy | 1 | Active |
| US11958891B2 | Tissue-specific Wnt signal enhancing molecules and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11773171B2 | WNT surrogate molecules and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US12006368B2 | Anti-frizzled antibodies and methods of use | Chemistry; Metallurgy | 1 | Active |
| US12240876B2 | Liver-specific Wnt signal enhancing molecules and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12297278B2 | Wnt surrogate molecules and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.